Alemtuzumab Treatment Results Published

Alemtuzumab, an antibody therapy, was studied in a Phase II clinical trial.  The results of the trial were published in the New England Journal of Medicine on October 23, 2008.  For details on this experimental medication and to find about the Phase III trial, visit the clinical trial section.